Charles Schwab Investment Management Inc. Increases Stock Position in Agilon Health, Inc. $AGL

Charles Schwab Investment Management Inc. raised its position in shares of Agilon Health, Inc. (NYSE:AGL) by 8.8% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,939,576 shares of the company’s stock after buying an additional 398,027 shares during the period. Charles Schwab Investment Management Inc. owned about 1.20% of Agilon Health worth $21,388,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Humankind Investments LLC purchased a new stake in Agilon Health during the 4th quarter valued at $30,000. Raymond James Financial Inc. purchased a new stake in Agilon Health during the 4th quarter valued at $33,000. Cerity Partners LLC purchased a new stake in Agilon Health during the 4th quarter valued at $34,000. Nisa Investment Advisors LLC boosted its position in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after buying an additional 6,783 shares during the period. Finally, Boothbay Fund Management LLC purchased a new stake in Agilon Health during the 4th quarter valued at $58,000.

Wall Street Analyst Weigh In

Several brokerages have commented on AGL. Sanford C. Bernstein restated a “market perform” rating and issued a $1.40 price objective (down from $4.00) on shares of Agilon Health in a report on Wednesday. Wells Fargo & Company decreased their price objective on shares of Agilon Health from $6.00 to $5.00 and set an “overweight” rating for the company in a report on Tuesday, May 13th. Benchmark decreased their price objective on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a report on Wednesday, August 6th. Robert W. Baird decreased their price objective on shares of Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Finally, Jefferies Financial Group decreased their price target on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a research note on Friday, August 15th. Four analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus target price of $3.07.

Agilon Health Stock Performance

Shares of AGL stock opened at $1.2350 on Friday. Agilon Health, Inc. has a one year low of $0.71 and a one year high of $6.08. The company’s 50-day moving average is $1.87 and its 200 day moving average is $3.00. The company has a market capitalization of $511.81 million, a price-to-earnings ratio of -1.60 and a beta of 0.14.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The firm had revenue of $1.39 billion for the quarter, compared to analysts’ expectations of $1.47 billion. During the same period last year, the company posted ($0.07) earnings per share. The business’s revenue for the quarter was down 5.9% compared to the same quarter last year. As a group, research analysts predict that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.